Non-steroidal anti-inflammatory drugs and amyotrophic lateral sclerosis: Results from five prospective cohort studies

Amyotrophic Lateral Sclerosis

Volumn 13, Issue 6, 2012, Pages 573-579

  Fondell, Elinor ^a   O'Reilly, Éilis J ^a   Fitzgerald, Kathryn C ^a   Falcone, Guido J ^a,b   McCullough, Marjorie L ^c   Thun, Michael J ^d   Park, Yikyung ^e   Kolonel, Laurence N ^e   Ascherio, Alberto ^a,f  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c AMERICAN CANCER SOCIETY   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

^e UNIVERSITY OF HAWAII   (United States)

^f BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

ALS; Cohort; Epidemiology; NSAID

Indexed keywords

ACETYLSALICYLIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; REVIEW; RISK ASSESSMENT; TREATMENT DURATION;

AGED; AMYOTROPHIC LATERAL SCLEROSIS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; COHORT STUDIES; COMMUNITY HEALTH PLANNING; FEMALE; HUMANS; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; QUESTIONNAIRES; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME;

EID: 84866101830     PISSN: 17482968     EISSN: 1471180X     Source Type: Journal    
DOI: 10.3109/17482968.2012.703209     Document Type: Review

References (40)

1. Philips T, R obberecht W. N euroinfl ammation in amyotrophic lateral sclerosis: Role of glial activation in motor neuron disease . Lancet Neurol. 2011; 10 : 253 - 63 .
2. Kuehl FA Jr, E gan RW. P rostaglandins, arachidonic acid, and infl ammation . Science. 1980; 210 : 978 - 84 .
3. Klegeris A, M cGeer PL. C yclooxygenase and 5-lipoxygenase inhibitors protect against mononuclear phagocyte neurotoxicity . Neurobiol Aging. 2002; 23 : 787 - 94 .
4. Carty ML, W ixey JA, R einebrant HE, G obe G, C olditz PB, Buller KM . Ibuprofen inhibits neuroinfl ammation and attenuates white matter damage following hypoxia-ischemia in the immature rodent brain . Brain Res. 2011; 1402 : 9 - 19 .
5. Drachman D B, F rank K, D ykes-Hoberg M, T eismann P, Almer G, Przedborski S, et al . Cyclooxygenase 2 inhibition protects motor neurons and prolongs survival in a transgenic mouse model of ALS . Ann Neurol. 2002; 52 : 771 - 8 .
6. Pompl P N, H o L, B ianchi M, M cManus T, Q in W, P asinetti GM. A therapeutic role for cyclooxygenase-2 inhibitors in a transgenic mouse model of amyotrophic lateral sclerosis . FASEB J. 2003; 17 : 725 - 7 .
7. Cudkowicz M E, Shefner J M, Schoenfeld D A, Zhang H, Andreasson KI, Rothstein JD, et al . Trial of celecoxib in amyotrophic lateral sclerosis . Ann Neurol. 2006; 60 : 22 - 31 .
8. Popat RA, T anner CM, v an den Eeden SK, B ernstein A L, Bloch DA, Leimpeter A, et al . Effect of non-steroidal anti-infl ammatory medications on the risk of amyotrophic lateral sclerosis . Amyotroph Lateral Scler. 2007; 8 : 157 - 63 . Rimm
9. E B, G iovannucci EL, W illett WC, C olditz GA, Ascherio A, Rosner B, et al . Prospective study of alcohol consumption and risk of coronary disease in men . Lancet. 1991; 338 : 464 - 8 .
10. Colditz G A, M anson J E, H ankinson S E. T he Nurses' Health Study: 20-year contribution to the understanding of health among women . J Womens Health. 1997; 6 : 49 - 62 .
11. Calle EE, R odriguez C, J acobs E J, Almon ML, Chao A, McCullough ML, et al . The American Cancer Society Cancer Prevention Study II Nutrition Cohort: Rationale, study design, and baseline characteristics . Cancer. 2002; 94 : 2490 - 501 .
12. Kolonel LN, H enderson BE, H ankin JH, N omura AM, Wilkens LR, Pike MC, et al . A multiethnic cohort in Hawaii and Los Angeles: baseline characteristics . Am J Epidemiol. 2000; 151 : 346 - 57 .
13. Leitzmann M F, P ark Y, B lair A, B allard-Barbash R, Mouw T, Hollenbeck AR, et al . Physical activity recommendations and decreased risk of mortality . Arch Intern Med. 2007; 167 : 2453 - 60 .
14. Wang H, O 'Reilly EJ, W eisskopf MG, L ogroscino G, McCullough ML, Thun MJ, et al . Smoking and risk of amyotrophic lateral sclerosis: A pooled analysis of fi ve prospective cohorts . Arch Neurol. 2011; 68 : 207 - 13 .
15. Weisskopf MG, M cCullough ML, C alle EE, T hun MJ, Cudkowicz M, Ascherio A . Prospective study of cigarette smoking and amyotrophic lateral sclerosis . Am J Epidemiol. 2004; 160 : 26 - 33 .
16. Brooks BR, M iller RG, S wash M, M unsat T L. E l Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis . Amyotroph Lateral Scler Other Motor Neuron Disord. 2000; 1 : 293 - 9 .
17. Gao X, C hen H, S chwarzschild M A, A scherio A. U se of ibuprofen and risk of Parkinson's disease . Neurology. 2011; 76 : 863 - 9 .
18. Manson JE, S tampfer MJ, C olditz GA, W illett WC, Rosner B, Speizer FE, et al . A prospective study of aspirin use and primary prevention of cardiovascular disease in women . JAMA. 1991; 266 : 521 - 7 .
19. Curhan GC, K night EL, R osner B, H ankinson SE, Stampfer MJ . Lifetime non-narcotic analgesic use and decline in renal function in women . Arch Intern Med. 2004; 164 : 1519 - 24 .
20. DerSimonian R, L aird N. M eta-analysis in clinical trials. Control Clin Trials. 1986; 7 : 177 - 88 .
21. Rothman KJ, G reenland S, L ash TL. M odern epidemiology. 3rd edn . Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins; 2008 .
22. Wang H, O 'Reilly E J, W eisskopf M G, L ogroscino G, McCullough ML, Schatzkin A, et al . Vitamin E intake and risk of amyotrophic lateral sclerosis: A pooled analysis of data from fi ve prospective cohort studies . Am J Epidemiol. 2011; 173 : 595 - 602 .
23. Logroscino G, T raynor BJ, H ardiman O, C hio A, C ouratier P, Mitchell JD, et al . Descriptive epidemiology of amyotrophic lateral sclerosis: New evidence and unsolved issues . J Neurol Neurosurg Psychiatry. 2008; 79 : 6 - 11 .
24. Armon C. A n evidence-based medicine approach to the evaluation of the role of exogenous risk factors in sporadic amyotrophic lateral sclerosis . Neuroepidemiology. 2003; 22 : 217 - 28 .
25. Hoffman P M, B rody J A. T he reliability of death certifi cate reporting for amyotrophic lateral sclerosis . J Chronic Dis. 1971; 24 : 5 - 8 .
26. Chio A. R isk factors in the early diagnosis of ALS: European epidemiological studies . Amyotroph Lateral Scler Other Motor Neuron Disord. 2000; 1(Suppl 1) : S13 - 8 .
27. del Aguila MA, L ongstreth WT Jr, M cGuire V, K oepsell TD, van Belle G . Prognosis in amyotrophic lateral sclerosis: A population based study . Neurology. 2003; 60 : 813 - 9 .
28. Cho E, C urhan G, H ankinson SE, K antoff P, A tkins MB, Stampfer M, et al . Prospective evaluation of analgesic use and risk of renal cell cancer . Arch Intern Med. 2011; 171 : 1487 - 93 .
29. Forman JP, R imm EB, C urhan GC. F requency of analgesic use and risk of hypertension among men . Arch Intern Med. 2007; 167 : 394 - 9 .
30. Chio A, C anosa A, G allo S, M oglia C, I lardi A, Cammarosano S, et al . Pain in amyotrophic lateral sclerosis: A population based controlled study . Eur J Neurol. 2011; 19 : 551 - 5 .
31. Cellura E, S pataro R, T aiello AC, L a Bella V. F actors affecting the diagnostic delay in amyotrophic lateral sclerosis . Clin Neurol Neurosurg. 2011; 114 : 550 - 4 .
32. Kano O, B eers DR, H enkel JS, A ppel SH. P eripheral nerve infl ammation in ALS mice: Cause or consequence . Neurology. 2012; 78 : 833 - 5 .
33. Moisse K, S trong MJ . I nnate immunity in amyotrophic lateral sclerosis . Biochim Biophys Acta. 2006 ; 1762 : 1083 - 93 .
34. Schwartz M, S hechter R. S ystemic infl ammatory cells fi ght off neurodegenerative disease . Nat Rev Neurol. 2010; 6 : 405 - 10 .
35. McCombe PA, H enderson RD. T he role of immune and infl ammatory mechanisms in ALS . Curr Mol Med. 2011; 11 : 246 - 54 .
36. Klivenyi P, Kiaei M, Gardian G, Calingasan N Y, Beal M F . Additive neuroprotective effects of creatine and cyclooxygenase 2 inhibitors in a transgenic mouse model of amyotrophic lateral sclerosis . J Neurochem. 2004; 88 : 576 - 82 .
37. Qureshi M, S hui A, D ibernardo AB, B rown R H J r, Schoenfeld DA, Cudkowicz ME . Medications and laboratory parameters as prognostic factors in amyotrophic lateral sclerosis . Amyotroph Lateral Scler. 2008; 9 : 369 - 74 .
38. Chen H, Z hang SM, H ernan MA, S chwarzschild MA, Willett WC, Colditz GA, et al . Non-steroidal antiinfl ammatory drugs and the risk of Parkinson's disease . Arch Neurol. 2003; 60 : 1059 - 64 .
39. Pasqualetti P, B onomini C, D al Forno G, P aulon L, Sinforiani E, Marra C, et al . A randomized controlled study on effects of ibuprofen on cognitive progression of Alzheimer's disease . Aging Clin Exp Res. 2009; 21 : 102 - 10 .
40. McKee A C, C arreras I, H ossain L, R yu H, K lein WL, Oddo S, et al . Ibuprofen reduces Abeta, hyperphosphorylated tau and memory defi cits in Alzheimer mice . Brain Res. 2008; 1207 : 225 - 36 .